Yibei Xiao
- Topics
- Cancer Immunotherapy and Biomarkers (14 papers)CAR-T cell therapy research (13 papers)Peptidase Inhibition and Analysis (8 papers)
- Journals
- ScienceProceedings of the National Academy of SciencesJournal of the American Chemical Society
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Yibei Xiao
56 papers receiving 762 citations
Peers
Comparison fields: 5 of 77
- Molecular Biology 377
- Oncology 250
- Immunology 134
- Organic Chemistry 125
- Infectious Diseases 90
Countries citing papers authored by Yibei Xiao
This map shows the geographic impact of Yibei Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yibei Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yibei Xiao more than expected).
Fields of papers citing papers by Yibei Xiao
This network shows the impact of papers produced by Yibei Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yibei Xiao. The network helps show where Yibei Xiao may publish in the future.
Co-authorship network of co-authors of Yibei Xiao
This figure shows the co-authorship network connecting the top 25 collaborators of Yibei Xiao. A scholar is included among the top collaborators of Yibei Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yibei Xiao. Yibei Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 3 | |
| 5 | 13 | |
| 6 | 18 | |
| 7 | 3 | |
| 8 | 2 | |
| 9 | 0 | |
| 10 | 1 | |
| 11 | 5 | |
| 12 | 5 | |
| 13 | 4 | |
| 14 | 22 | |
| 15 | 17 | |
| 16 | 10 | |
| 17 | 10 | |
| 18 | 13 | |
| 19 | 33 | |
| 20 | 25 |
About Yibei Xiao
Yibei Xiao is a scholar working on Oncology, Molecular Biology and Immunology, having authored 60 papers that have together received 766 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), CAR-T cell therapy research (13 papers) and Peptidase Inhibition and Analysis (8 papers). The work is most often cited by research in Oncology (250 citations), Business and International Management (15 citations) and Immunology (134 citations). Yibei Xiao has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Sheng Jiang, Yao Cheng, Tianyu Wang, Peng Yang, Kuojun Zhang, Ailong Ke, Wanheng Zhang, Wenjian Min, Huiyong Sun and Xiangyu Zhang. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.